Daily Newsletter

23 November 2023

Daily Newsletter

23 November 2023

EyeCare4Kids opens eye care clinic at hospital in Juja, Kenya

The project has been built using donations from individuals and corporations.

November 23 2023

US-based healthcare non-profit EyeCare4Kids has opened an advanced vision clinic at Kalimoni Mission Hospital in Juja, Kenya.

Built using donations from individuals and corporations, the clinic includes a hospital wing and up-to-date examination equipment.

The project has been in development for several years and was impacted by the Covid-19 pandemic.

EyeCare4Kids founder Joseph Carbone said: “The new vision clinic at Kalimoni Mission Hospital, located in Kenya, was made possible because of the unwavering support of donors and the tireless efforts of so many of our partners and friends.

“The clinic officially began serving patients in the summer, marking a significant milestone in the organisation's mission to improve eye health around the world.”

As part of the Sight the World initiative and in partnership with 1-800 CONTACTS, the clinic makes use of mobile devices for refractions.

Glasses are made locally or supplemented by EyeCare4Kids, with the non-profit covering all shipping to the hospital.

Carbone added: “The vision clinic at Kalimoni Mission Hospital is a leap forward in eye care for the local residents and will empower the people of Kenya to become more self-reliant.

“EyeCare4Kids remains committed to its mission, striving to make a meaningful difference in the lives of individuals and communities around the world."

EyeCare4Kids held an opening ceremony for the clinic, which was attended by Archbishop of Nairobi Philip Anyolo.

Commending EyeCare4Kids and Carbone's efforts, Archbishop Anyolo described the clinic as 'the finest eye care facility' in Kenya.

Founded in 2001, EyeCare4Kids provides eye care to visually impaired children and underserved families.

The organisation has served more than 400,000 children to date and aims to serve more than 500,000 by 2025.

It operates clinics in the US and is expanding worldwide, with several clinics open and planned for development in Africa.

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close